NCT07048626

Brief Summary

Low-level laser stimulates cells in the hair follicles, which promotes hair growth. The patient's own blood platelets are used in platelet-rich plasma treatment to encourage hair growth. Combining low-level laser treatment with platelet-rich plasma will promote hair growth in patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 17, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 24, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 2, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

July 2, 2025

Status Verified

June 1, 2025

Enrollment Period

6 months

First QC Date

June 24, 2025

Last Update Submit

June 24, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Physician's Global Assessment (PGA) scale

    The Physician's Global Assessment (PGA) scale is a tool used by physicians to evaluate the overall severity of a patient's disease. It's a subjective assessment, typically on a scale of 0 to 3 or 0 to 4, with higher scores indicating more severe disease activity. The PGA focuses on the overall disease activity, considering both the severity of active manifestations and relevant laboratory results, excluding organ damage and subjective findings unrelated to disease activity

    12 Months

Study Arms (2)

PRP treatment

EXPERIMENTAL
Combination Product: PRP treatment

low leve laser therapy post prp treatment

ACTIVE COMPARATOR
Combination Product: low level laser therapy post prp treatment

Interventions

PRP treatmentCOMBINATION_PRODUCT

PRP treatment involves drawing a blood sample, processing it to concentrate platelets, and then injecting that concentrated plasma back into the body, typically at the site of an injury or area needing regeneration. The procedure aims to utilize the growth factors within the platelets to accelerate healing and tissue repair.

PRP treatment

will receive low-level laser therapy post prp treatment upto 12 weeks .Low-level laser therapy (LLLT) is a non-invasive treatment for hair loss that uses low-intensity laser light to stimulate hair follicles and improve blood circulation. It's often used on its own or combined with other therapies like PRP.

low leve laser therapy post prp treatment

Eligibility Criteria

Age20 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Adults between 18-35 years diagnosed with androgenic alopecia or other non-scarring hair loss conditions.
  • Having the Norwood-Hamilton scale placed in stages I-V for men Ludwig scale in stages I-III for women .

You may not qualify if:

  • Use of systemic medications (e.g., corticosteroids, immunosuppressants) or treatments affecting hair regrowth within the last 3 months.
  • History of hypersensitivity or adverse reactions to laser therapy
  • Active systemic diseases such as uncontrolled diabetes, autoimmune disorders, or malignancies
  • Pregnant or breastfeeding individuals.
  • Patients with pacemakers or implanted medical devices contraindicated with low level laser therapy.
  • History of hair transplant surgery in the treatment area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Reshape Clinic

Lahore, Pakistan

Location

MeSH Terms

Conditions

Alopecia

Condition Hierarchy (Ancestors)

HypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 24, 2025

First Posted

July 2, 2025

Study Start

March 17, 2025

Primary Completion

September 1, 2025

Study Completion

February 28, 2026

Last Updated

July 2, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations